antiepileptic drug

Teriflunomide.

Published August 6, 2013

Teriflunomide.

Neurol Clin Pract. 2013 Jun; 3(3): 254-260
Oh J, O’Connor PW

Teriflunomide is a novel disease-modifying agent that was recently approved for use in the treatment of multiple sclerosis (MS). Teriflunomide has demonstrated clinical efficacy and safety in… Continue reading →

Predicting Self-Initiated Marijuana Use Cessation Among Youth at Continuation High Schools.

Published July 31, 2013

Predicting Self-Initiated Marijuana Use Cessation among Youth at Continuation High Schools.

Front Psychiatry. 2013; 4: 69
Little MA, Spruijt-Metz D, Pokhrel P, Sun P, Rohrbach LA, Sussman S

The current article reports a large scale study of the prediction… Continue reading →

Gabapentin Add-on for Drug-Resistant Partial Epilepsy.

Published July 28, 2013

Gabapentin add-on for drug-resistant partial epilepsy.

Cochrane Database Syst Rev. 2013 Jul 25; 7: CD001415
Al-Bachari S, Pulman J, Hutton JL, Marson AG

The majority of people with epilepsy have a good prognosis and their seizures are well controlled… Continue reading →

Current and Emerging Treatments for Absence Seizures in Young Patients.

Published July 27, 2013

Current and emerging treatments for absence seizures in young patients.

Neuropsychiatr Dis Treat. 2013; 9: 963-75
Vrielynck P

In this report, we review the pharmacological and non-pharmacological treatments of the different absence seizure types as recently recognized by the… Continue reading →

Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania Somnifera, Warbugia Ugandensis, Prunus Africana and Plectrunthus Barbatus.

Published June 21, 2013

Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus.

PLoS One. 2013; 8(6): e65619
Mwitari PG, Ayeka PA, Ondicho J, Matu EN, Bii CC

Withania somnifera, Warbugia… Continue reading →

Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics.

Published June 19, 2013

Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics.

Int J Prev Med. 2013 May; 4(Suppl 2): S343-6
Tolou-Ghamari Z, Najafi MR, Habibabadi JM, Zare M

Carbamazepine (CBZ) is mostly considered as the first line of… Continue reading →

Corticomuscular Coherence Analysis on Hand Movement Distinction for Active Rehabilitation.

Published May 22, 2013

Corticomuscular Coherence Analysis on Hand Movement Distinction for Active Rehabilitation.

Comput Math Methods Med. 2013; 2013: 908591
Lou X, Xiao S, Qi Y, Hu X, Wang Y, Zheng X

Active rehabilitation involves patient’s voluntary thoughts as the control signals… Continue reading →

[Antibiotic-Associated Diarrhea in Clinical Practice].

Published May 9, 2013

[Antibiotic-associated diarrhea in clinical practice].

Ter Arkh. 2013; 85(2): 85-8

Antibiotic-associated diarrhea (AAD) is considered to mean at least 3 shapeless stool episodes within 2 or more consecutive days when using antibacterial agents. Due to the fact that antibiotics… Continue reading →

Multidrug-Resistance and Extended Spectrum Beta-Lactamase Production in Uropathogenic E. Coli Which Were Isolated From Hospitalized Patients in Kolkata, India.

Published May 2, 2013

Multidrug-Resistance and Extended Spectrum Beta-Lactamase Production in Uropathogenic E. Coli which were Isolated from Hospitalized Patients in Kolkata, India.

J Clin Diagn Res. 2013 Mar; 7(3): 449-53
Mukherjee M, Basu S, Mukherjee SK, Majumder M

Background and Objective: Urinary… Continue reading →

Update on the Treatment of Non-Small-Cell Lung Cancer: Focus on the Cost-Effectiveness of New Agents.

Published May 1, 2013

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents.

Clinicoecon Outcomes Res. 2013; 5: 137-41
Vergnenègre A, Borget I, Chouaid C

The incidence of lung cancer and the cost of drug treatment have… Continue reading →